Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Genes Brain Behav ; 18(1): e12475, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-29566304

RESUMEN

Oligodendrocyte gene expression is downregulated in stress-related neuropsychiatric disorders, including depression. In mice, chronic social stress (CSS) leads to depression-relevant changes in brain and emotional behavior, and the present study shows the involvement of oligodendrocytes in this model. In C57BL/6 (BL/6) mice, RNA-sequencing (RNA-Seq) was conducted with prefrontal cortex, amygdala and hippocampus from CSS and controls; a gene enrichment database for neurons, astrocytes and oligodendrocytes was used to identify cell origin of deregulated genes, and cell deconvolution was applied. To assess the potential causal contribution of reduced oligodendrocyte gene expression to CSS effects, mice heterozygous for the oligodendrocyte gene cyclic nucleotide phosphodiesterase (Cnp1) on a BL/6 background were studied; a 2 genotype (wildtype, Cnp1+/- ) × 2 environment (control, CSS) design was used to investigate effects on emotional behavior and amygdala microglia. In BL/6 mice, in prefrontal cortex and amygdala tissue comprising gray and white matter, CSS downregulated expression of multiple oligodendroycte genes encoding myelin and myelin-axon-integrity proteins, and cell deconvolution identified a lower proportion of oligodendrocytes in amygdala. Quantification of oligodendrocyte proteins in amygdala gray matter did not yield evidence for reduced translation, suggesting that CSS impacts primarily on white matter oligodendrocytes or the myelin transcriptome. In Cnp1 mice, social interaction was reduced by CSS in Cnp1+/- mice specifically; using ionized calcium-binding adaptor molecule 1 (IBA1) expression, microglia activity was increased additively by Cnp1+/- and CSS in amygdala gray and white matter. This study provides back-translational evidence that oligodendrocyte changes are relevant to the pathophysiology and potentially the treatment of stress-related neuropsychiatric disorders.


Asunto(s)
Oligodendroglía/metabolismo , Conducta Social , Estrés Psicológico/genética , Transcriptoma , Amígdala del Cerebelo/metabolismo , Animales , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/metabolismo , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 1/genética , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 1/metabolismo , Hipocampo/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/metabolismo , Corteza Prefrontal/metabolismo , Estrés Psicológico/metabolismo
2.
Cell Death Dis ; 5: e1222, 2014 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-24810058

RESUMEN

Assessment of the network of toxicity pathways by Omics technologies and bioinformatic data processing paves the road toward a new toxicology for the twenty-first century. Especially, the upstream network of responses, taking place in toxicant-treated cells before a point of no return is reached, is still little explored. We studied the effects of the model neurotoxicant 1-methyl-4-phenylpyridinium (MPP(+)) by a combined metabolomics (mass spectrometry) and transcriptomics (microarrays and deep sequencing) approach to provide unbiased data on earliest cellular adaptations to stress. Neural precursor cells (LUHMES) were differentiated to homogeneous cultures of fully postmitotic human dopaminergic neurons, and then exposed to the mitochondrial respiratory chain inhibitor MPP(+) (5 µM). At 18-24 h after treatment, intracellular ATP and mitochondrial integrity were still close to control levels, but pronounced transcriptome and metabolome changes were seen. Data on altered glucose flux, depletion of phosphocreatine and oxidative stress (e.g., methionine sulfoxide formation) confirmed the validity of the approach. New findings were related to nuclear paraspeckle depletion, as well as an early activation of branches of the transsulfuration pathway to increase glutathione. Bioinformatic analysis of our data identified the transcription factor ATF-4 as an upstream regulator of early responses. Findings on this signaling pathway and on adaptive increases of glutathione production were confirmed biochemically. Metabolic and transcriptional profiling contributed complementary information on multiple primary and secondary changes that contribute to the cellular response to MPP(+). Thus, combined 'Omics' analysis is a new unbiased approach to unravel earliest metabolic changes, whose balance decides on the final cell fate.


Asunto(s)
1-Metil-4-fenilpiridinio/toxicidad , Neuronas Dopaminérgicas/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Células-Madre Neurales/efectos de los fármacos , Síndromes de Neurotoxicidad/etiología , Transcripción Genética/efectos de los fármacos , Factor de Transcripción Activador 4/genética , Factor de Transcripción Activador 4/metabolismo , Adaptación Fisiológica , Adenosina Trifosfato/metabolismo , Línea Celular , Biología Computacional , Neuronas Dopaminérgicas/metabolismo , Neuronas Dopaminérgicas/patología , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica , Glucosa/metabolismo , Glutatión/metabolismo , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Espectrometría de Masas , Metabolómica/métodos , Mitocondrias/metabolismo , Mitocondrias/patología , Células-Madre Neurales/metabolismo , Células-Madre Neurales/patología , Síndromes de Neurotoxicidad/genética , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/patología , Análisis de Secuencia por Matrices de Oligonucleótidos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Fosfocreatina/metabolismo , Interferencia de ARN , Factores de Tiempo , Transfección
3.
Transfusion ; 45(7): 1073-83, 2005 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15987350

RESUMEN

BACKGROUND: An ongoing issue in transfusion medicine is whether newly identified or emerging pathogens can be transmitted by transfusion. One method to study this question is through the use of a contemporary linked donor-recipient repository. STUDY DESIGN AND METHODS: The Retrovirus Epidemiology Donor Study Allogeneic Donor and Recipient (RADAR) repository was established between 2000 and 2003 by seven blood centers and eight collaborating hospitals. Specimens from consented donors were collected, components from their donations were routed to participating hospitals, and recipients of these units gave enrollment and follow-up specimens for long-term storage. The repository was designed to show that zero transmissions to enrolled recipients would indicate with 95 percent confidence that the transfusion transmission rate of an agent with prevalence of 0.05 to 1 percent was lower than 25 percent. RESULTS: The repository contains pre- and posttransfusion specimens from 3,575 cardiac, vascular, and orthopedic surgery patients, linked to 13,201 donation specimens. The mean number of RADAR donation exposures per recipient is 3.85. The distribution of components transfused is 77 percent red cells, 13 percent whole blood-derived platelet concentrates, and 10 percent fresh frozen plasma. A supplementary unlinked donation repository containing 99,906 specimens from 84,339 donors was also established and can be used to evaluate the prevalence of an agent and validate assay(s) performance before accessing the donor-recipient-linked repository. Recipient testing conducted during the establishment of RADAR revealed no transmissions of human immunodeficiency virus, hepatitis C virus, or human T-lymphotropic virus. CONCLUSIONS: RADAR is a contemporary donor-recipient repository that can be accessed to study the transfusion transmissibility of emerging agents.


Asunto(s)
Bancos de Sangre , Donantes de Sangre , Hospitales , Reacción a la Transfusión , Virosis/sangre , Virosis/transmisión , Síndrome de Inmunodeficiencia Adquirida/sangre , Síndrome de Inmunodeficiencia Adquirida/transmisión , Infecciones por HTLV-I/sangre , Infecciones por HTLV-I/transmisión , Infecciones por HTLV-II/sangre , Infecciones por HTLV-II/transmisión , Hepatitis Viral Humana/sangre , Hepatitis Viral Humana/transmisión , Humanos , Prevalencia , Trasplante Homólogo , Estados Unidos , Virosis/epidemiología
4.
Transfusion ; 44(7): 973-6, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15225235

RESUMEN

BACKGROUND: In February 2002, a multiorganizational task force investigated blood center reports of unusual particulate matter (PM) visible in packed red blood cells (RBC). A cohort study assessed increase in adverse events (AEs) related to this phenomenon, as well as the effect of post-leukofiltration (LF) on PM. METHODS: Two blood centers assessed AEs in patients transfused with RBCs having visible PM (classified as normal by-products of RBC preparation), PM RBCs subsequently LF, or RBCs without visible PM, and the effect of LF on PM removal. RESULTS: There was no difference in AEs in patients transfused with PM RBCs with or without LF compared to patients transfused with RBCs without visible PM. Subsequently filtered PM RBCs had acceptable residual WBC counts and median platelet removal of 92%. CONCLUSION: Transfusion of RBCs with visible PM or RBCs subsequently LF does not appear to increase the risk of an AE. LF use on PM RBCs results in the PM removal without adversely affecting filter performance. The lack of evidence of an increase in AE reports does not mean that there is no effect, and there may be a baseline AE rate attributable to PM which has not been thoroughly researched.


Asunto(s)
Recolección de Muestras de Sangre , Transfusión de Eritrocitos/efectos adversos , Eliminación de Componentes Sanguíneos , Estudios de Cohortes , Filtración , Humanos , Leucocitos
5.
Transfusion ; 41(9): 1114-9, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11552067

RESUMEN

BACKGROUND: Because it has been increasingly recognized that Chlamydia pneumoniae may be linked to some chronic inflammatory diseases, including atherosclerosis, detection of this pathogen in blood from patients may be valuable in the diagnosis of such diseases. However, the prevalence of chlamydia in the blood of healthy donors has not yet been extensively studied. STUDY DESIGN AND METHODS: The presence of C. pneumoniae in PBMNCs obtained from healthy persons who donated blood for blood transfusion was assessed by a PCR that was specific for the C. pneumoniae 16S rRNA gene and by the use of staining with FITC-conjugated chlamydia MoAb. RESULTS: Twenty-one (8.9%) of 237 blood samples tested showed the presence of C. pneumoniae DNA and antigen in the PBMNCs. There was no significant difference in the presence of chlamydia in blood according to sex or to age between 20 and 59 years of age. However, a possible seasonal variation in the presence of chlamydia in blood from healthy donors was suggested by the results obtained. CONCLUSION: A significant percentage of healthy donors carry C. pneumoniae, which may be a risk factor for some chronic diseases.


Asunto(s)
Antígenos Bacterianos/sangre , Donantes de Sangre , Chlamydophila pneumoniae/inmunología , Monocitos/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Chlamydophila pneumoniae/genética , ADN Bacteriano/sangre , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Persona de Mediana Edad , Valores de Referencia
6.
Nat Biotechnol ; 19(4): 348-53, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11283593

RESUMEN

The rapid increase in genomic information requires new techniques to infer protein function and predict protein-protein interactions. Bioinformatics identifies modular signaling domains within protein sequences with a high degree of accuracy. In contrast, little success has been achieved in predicting short linear sequence motifs within proteins targeted by these domains to form complex signaling networks. Here we describe a peptide library-based searching algorithm, accessible over the World Wide Web, that identifies sequence motifs likely to bind to specific protein domains such as 14-3-3, SH2, and SH3 domains, or likely to be phosphorylated by specific protein kinases such as Src and AKT. Predictions from database searches for proteins containing motifs matching two different domains in a common signaling pathway provides a much higher success rate. This technology facilitates prediction of cell signaling networks within proteomes, and could aid in the identification of drug targets for the treatment of human diseases.


Asunto(s)
Genoma , Transducción de Señal , Algoritmos , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Bovinos , Bases de Datos Factuales , Humanos , Internet , Ratones , Datos de Secuencia Molecular , Ratas , Serina/química , Programas Informáticos , Treonina/química , Tirosina/química
7.
J Biol Chem ; 275(46): 36108-15, 2000 Nov 17.
Artículo en Inglés | MEDLINE | ID: mdl-10945990

RESUMEN

AKT was originally identified as a proto-oncogene with a pleckstrin homology and Ser/Thr protein kinase domains. Recent studies revealed that AKT regulates a variety of cellular functions including cell survival, cell growth, cell differentiation, cell cycle progression, transcription, translation, and cellular metabolism. To clarify the substrate specificity of AKT, we have used an oriented peptide library approach to determine optimal amino acids at positions N-terminal and C-terminal to the site of phosphorylation. The predicted optimal peptide substrate (Arg-Lys-Arg-Xaa-Arg-Thr-Tyr-Ser*-Phe-Gly where Ser* is the phosphorylation site) has similarities to but is distinct from optimal substrates that we previously defined for related basophilic protein kinases such as protein kinase A, Ser/Arg-rich kinases, and protein kinase C family members. The positions most important for high V(max)/K(m) ratio were Arg-3>Arg-5>Arg-7. The substrate specificity of AKT was further investigated by screening a lambdaGEX phage HeLa cell cDNA expression library. All of the substrates identified by this procedure contained Arg-Xaa-Arg-Xaa-Xaa-(Ser/Thr) motifs and were in close agreement with the motif identified by peptide library screening. The results of this study should help in prediction of likely AKT substrates from primary sequences.


Asunto(s)
Biblioteca de Péptidos , Péptidos/química , Péptidos/metabolismo , Proteínas Serina-Treonina Quinasas , Proteínas Proto-Oncogénicas/metabolismo , Proteínas 14-3-3 , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Aminoácidos/genética , Aminoácidos/metabolismo , Animales , Sitios de Unión , Clonación Molecular , Secuencia de Consenso , Biblioteca de Genes , Células HeLa , Humanos , Cinética , Ratones , Modelos Moleculares , Datos de Secuencia Molecular , Ácidos Fosfoaminos/análisis , Fosforilación , Estructura Terciaria de Proteína , Proto-Oncogenes Mas , Proteínas Proto-Oncogénicas/química , Proteínas Proto-Oncogénicas c-akt , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , Tirosina 3-Monooxigenasa/metabolismo
8.
J Biol Chem ; 275(36): 28167-72, 2000 Sep 08.
Artículo en Inglés | MEDLINE | ID: mdl-10862767

RESUMEN

Regulator of G protein signaling (RGS) proteins function as GTPase-activating proteins (GAPs) that stimulate the inactivation of heterotrimeric G proteins. We have recently shown that RGS proteins may be regulated on a post-translational level (Benzing, T., Brandes, R., Sellin, L., Schermer, B., Lecker, S., Walz, G., and Kim, E. (1999) Nat. Med. 5, 913-918). However, mechanisms controlling the GAP activity of RGS proteins are poorly understood. Here we show that 14-3-3 proteins associate with RGS7 and RGS3. Binding of 14-3-3 is mediated by a conserved phosphoserine located in the Galpha-interacting portion of the RGS domain; interaction with 14-3-3 inhibits the GAP activity of RGS7, depends upon phosphorylation of a conserved residue within the RGS domain, and results in inhibition of GAP function. Collectively, these data indicate that phosphorylation-dependent binding of 14-3-3 may act as molecular switch that controls the GAP activity keeping a substantial fraction of RGS proteins in a dormant state.


Asunto(s)
Proteínas de Unión al GTP , Proteínas Activadoras de GTPasa/metabolismo , Proteínas/metabolismo , Proteínas RGS/metabolismo , Proteínas Represoras , Tirosina 3-Monooxigenasa , Proteínas 14-3-3 , Secuencia de Aminoácidos , Sitios de Unión , Línea Celular , Humanos , Cinética , Datos de Secuencia Molecular , Mutagénesis Insercional , Mutagénesis Sitio-Dirigida , Fosforilación , Proteínas RGS/química , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Estaurosporina/farmacología , Transfección
9.
Photochem Photobiol ; 71(5): 610-9, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10818792

RESUMEN

Multiwavelength ultraviolet-visible (UV-Vis) transmission spectroscopy is a relatively simple technique that can provide considerable quantitative information on the properties of micron and submicron particle suspensions. Two important particle properties are particle size distribution (PSD) and chemical composition. These properties provide characteristics for the identification and classification of biological systems ranging in size and composition from proteins and nucleic acids to cells. By measuring the complete UV-Vis spectrum, the combined scattering and absorption properties are obtained as a function of wavelength. The quantitative evaluation of the size distribution and chemical composition is accomplished through the application of light-scattering theory. This paper reports on the estimation of the optical properties of human blood platelets and their use in the interpretation of platelet UV-Vis spectra within the context of Mie theory. The model developed herein provides reliable and accurate estimates for the PSD and particle number of platelet suspensions. One potential application of this characterization method is in the analysis of platelet activation by thrombin. Quantification of spectral data with respect to average particle size and particle number provides a real-time description of the dramatic changes that accompany the platelet activation process.


Asunto(s)
Plaquetas/química , Células Cultivadas , Humanos , Luz , Modelos Biológicos , Activación Plaquetaria , Dispersión de Radiación
10.
Transfusion ; 39(10): 1051-9, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10532597

RESUMEN

BACKGROUND: A new blood typing technology based on ultraviolet (UV) and visible light spectroscopy (UV/visible spectroscopy) has been developed. Blood groups and types are determined by quantifying reproducible changes in the UV and visible light spectra of blood in the presence of agglutinating antibodies. STUDY DESIGN AND METHODS: Samples of red cells in the presence and absence of agglutinating antibodies were examined by UV/visible spectroscopy. Blood groups and types were determined by comparing the optical density spectra obtained between 665 and 1000 nm. These comparisons generate numbers (agglutination index) ranging from 0 to 100, with smaller numbers corresponding to lack of agglutination and larger numbers corresponding to agglutination. RESULTS: The optical density of agglutinated blood is dramatically different from that of unagglutinated blood. The agglutination index derived from the relative slopes of the spectra is an objective indicator of agglutination strength. An agglutination index greater than 17 consistently and accurately established blood group- and type-specific agglutination. CONCLUSION: The method accurately predicted A, B, and O blood groups, and D type in over 275 samples. Scattering theory-based calculations of relative volumes of red cells before and after agglutination show a direct correlation with the agglutination index and provide the theoretical basis of the analysis. This quantitative technique is reproducible and has the potential for automation.


Asunto(s)
Tipificación y Pruebas Cruzadas Sanguíneas/métodos , Pruebas de Hemaglutinación , Espectrofotometría , Rayos Ultravioleta , Hemaglutinación , Humanos , Modelos Biológicos , Reproducibilidad de los Resultados , Dispersión de Radiación , Sensibilidad y Especificidad
11.
Am J Obstet Gynecol ; 181(3): 744-9, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10486493

RESUMEN

OBJECTIVE: Our aim was to describe the treatment of iatrogenic previable premature rupture of membranes with the intra-amniotic injection of platelets and cryoprecipitate (amniopatch). STUDY DESIGN: Patients with iatrogenic previable premature rupture of membranes and without evidence of intra-amniotic infection underwent transabdominal intra-amniotic injection of platelets and cryoprecipitate through a 22-gauge needle. The study was approved by the Institutional Review Board of St Joseph's Hospital in Tampa, Florida, and all patients gave written informed consent. RESULTS: Seven patients with iatrogenic preterm premature rupture of membranes underwent placement of an amniopatch. Membrane sealing was verifiable in 6 of 7 patients. Three patients had iatrogenic preterm premature rupture of membranes after operative fetoscopy, 3 cases were after genetic amniocentesis, and 1 was after diagnostic fetoscopy. Three pregnancies progressed well, with restoration of the amniotic fluid volume and no further leakage. Two patients had unexplained fetal death despite successful sealing. One case of bladder outlet obstruction had no further leakage, but oligohydramnios persisted and did not allow unequivocal documentation of sealing. One patient miscarried from twin-twin transfusion, but the amniotic cavity was sealed. CONCLUSIONS: Iatrogenic preterm premature rupture of membranes can be treated effectively with an amniopatch. The technique is simple and does not require knowledge of the exact location of the defect. Unexpected fetal death from the procedure may be attributable to vasoactive effects of platelets or indigo carmine. Although the appropriate dose of platelets and cryoprecipitate needs to be established, the amniopatch may mean that iatrogenic preterm premature rupture of membranes no longer needs to be considered a devastating complication of pregnancy.


Asunto(s)
Amnios , Plaquetas , Rotura Prematura de Membranas Fetales/terapia , Enfermedad Iatrogénica , Plasma , Adulto , Amniocentesis/efectos adversos , Femenino , Rotura Prematura de Membranas Fetales/etiología , Transfusión Feto-Fetal/cirugía , Fetoscopía/efectos adversos , Edad Gestacional , Humanos , Inyecciones , Oligohidramnios/prevención & control , Complicaciones Posoperatorias , Embarazo , Ultrasonografía Prenatal
12.
Vox Sang ; 74(1): 27-30, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9481857

RESUMEN

BACKGROUND AND OBJECTIVES: To determine the cause of hypotensive reactions associated with platelet transfusions in coronary artery bypass surgery patients. MATERIALS AND METHODS: Platelet transfusion reactions that occurred during a 3-month period were retrospectively reviewed. RESULTS: Eighteen transfusion reactions occurred in 16 patients. Sixteen of the reactions were hypotensive and occurred in 14 patients transfused with platelets through negatively charged bedside leukocyte reduction filters. All 14 patients had received angiotensin-converting enzyme (ACE) inhibitors prior to transfusion. CONCLUSION: Preliminary findings suggest a new type of transfusion reaction associated with the use of negatively charged leukocyte reduction filters during platelet transfusions to patients on ACE inhibitors.


Asunto(s)
Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Hipotensión/inducido químicamente , Hipotensión/etiología , Transfusión de Plaquetas/efectos adversos , Anciano , Anciano de 80 o más Años , Eliminación de Componentes Sanguíneos/efectos adversos , Femenino , Filtración/métodos , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
13.
Am J Clin Pathol ; 106(2): 163-9, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8712167

RESUMEN

This practice guideline represents the opinions and recommendations of the author(s), the American Society of Clinical Pathologists (ASCP) Practice Parameters Committee and the ASCP Board of Directors regarding the appropriate strategies for each clinical condition or laboratory test discussed in this guideline. This guideline is designed primarily as an educational resource for physicians in the provision of quality medical services. Adherence to this guideline is completely voluntary and does not necessarily assure a successful medical treatment or result. This practice guideline should not be considered inclusive of all proper procedures and tests or exclusive of other procedures or tests that are reasonably directed to obtaining the same results. The physician should apply his or her own professional judgment to the unique clinical circumstances presented by the particular procedure or test. Physicians are encouraged to document the reasons for whatever procedure or test they use (whether or not in conformance with this guideline). Physicians should also take care to consider other medical and scientific advances that are available after the date of adoption of this guideline. This practice guideline was developed exclusively for the purposes set forth above and not for use in connection with matters involving reimbursement, credentialing, or utilization review.


Asunto(s)
Infecciones por Citomegalovirus/prevención & control , Transfusión de Eritrocitos/efectos adversos , Transfusión de Plaquetas/efectos adversos , Adulto , Análisis Costo-Beneficio , Infecciones por Citomegalovirus/transmisión , Transfusión de Eritrocitos/economía , Filtración , Indicadores de Salud , Humanos , Huésped Inmunocomprometido , Recién Nacido , Tamizaje Masivo/métodos , Transfusión de Plaquetas/economía , Prevención Primaria/métodos , Sociedades Médicas , Donantes de Tejidos , Estados Unidos
14.
Am J Clin Pathol ; 106(1): 6-11, 1996 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-8701934

RESUMEN

Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare but fatal potential complication of transfusions. It is mediated by immunocompetent donor lymphocytes that cannot be eliminated by the recipient. Patients at risk for developing TA-GVHD are those who have a profound deficiency in cell-mediated immunity or those who share histocompatibility antigens with the donor and do not recognize the donor cells as foreign. Irradiation of cellular blood components is currently the only acceptable method for prevention of TA-GVHD. This practice guideline identifies the patient population who should receive irradiated blood components and describes the technical aspects of blood component irradiation that may affect the safety of the final product.


Asunto(s)
Células Sanguíneas/efectos de la radiación , Transfusión de Componentes Sanguíneos/métodos , Transfusión de Componentes Sanguíneos/normas , Enfermedad Injerto contra Huésped/prevención & control , Relación Dosis-Respuesta en la Radiación , Rayos gamma , Enfermedad Injerto contra Huésped/etiología , Humanos , Patología Clínica/métodos , Patología Clínica/normas , Control de Calidad , Factores de Riesgo , Sociedades Médicas , Estados Unidos
15.
Infect Dis Obstet Gynecol ; 3(2): 60-3, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-18476021

RESUMEN

OBJECTIVE: The purpose of this study was to evaluate the possible association between Lewis phenotype status in pregnant women and preterm labor (PTL) or preterm rupture of the membranes (PROM). METHODS: Red blood cell (RBC) Lewis phenotype was determined in 113 pregnant women admitted for PTL or PROM and in 121 controls. The results were controlled for the influence of race on Lewis phenotype. RESULTS: Pregnancy was associated with a higher frequency in women with the a-b- phenotype. There was no association between RBC Lewis phenotype and the occurrence of PTL or PROM. CONCLUSIONS: A susceptibility to PTL or PROM is not due to a lack of Lewis antigen expression on the plasma membrane of the vaginal mucosa.

16.
Am Surg ; 58(2): 104-7, 1992 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1550300

RESUMEN

This study was undertaken to evaluate the association between red blood cell transfusions and infections in an easily stratified, homogenous group of injured adults. All received their initial transfusions upon arrival to the emergency department. Over 5 years, 390 uncross-matched trauma patients received type "O" red blood cells (RBCs) during initial resuscitation. One hundred fifty-four (39%) died within 7 days because of injuries sustained: 236 (61%) survived at least 7 days. Of these 236, clear differences could be seen between those receiving 6 or fewer or 7 or more units of RBCs. When adjusted for age, sex, and severity of injury (Champion Trauma Score, Injury Severity Score, TRISS), the risk of infection was higher in those receiving 7 or more units of RBCs. Similarly, risk of infection was related to units of RBCs transfused in a dose-related fashion. Blood transfusions should be avoided, if possible. Arbitrary "trigger points" for transfusions should be abandoned.


Asunto(s)
Infecciones Bacterianas/etiología , Reacción a la Transfusión , Heridas y Lesiones/complicaciones , Sistema del Grupo Sanguíneo ABO , Adulto , Transfusión de Eritrocitos , Femenino , Humanos , Puntaje de Gravedad del Traumatismo , Intestinos/lesiones , Masculino , Modelos de Riesgos Proporcionales , Análisis de Regresión , Factores de Riesgo , Tasa de Supervivencia , Índices de Gravedad del Trauma
17.
J Fla Med Assoc ; 78(7): 423-5, 1991 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1919494

RESUMEN

At present, few institutions consider separate informed consent for blood transfusions; rather, the patient gives this consent as part of a more comprehensive statement. This should change in the era of increasing patient's rights. The physician has the moral duty to fully inform the patient of the risks and benefits involved in the planned therapy. A separate consent requires time and paperwork but if done properly, it benefits the patients by increasing their knowledge and autonomy in the transfusion process.


Asunto(s)
Transfusión Sanguínea , Consentimiento Informado , Bioética , Formularios de Consentimiento , Humanos , Defensa del Paciente , Factores de Riesgo , Reacción a la Transfusión
18.
Crit Rev Clin Lab Sci ; 28(5-6): 387-403, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1772586

RESUMEN

Leukocyte-poor blood components (LPBC) have now become part of the armamentarium of available transfusable blood components. Indications for the use of LPBC vary in accordance with the underlying clinical condition, as well as the intended objectives of the transfusion therapy. Technological advances have made it possible to prepare LPBC using rather simple procedures. However, any manipulation of blood components and the additional use of filters, washing, rinsing solutions, etc. inevitably result in additional costs to the patient, the health-care institution, or third-party payers. Requests for LPBC involve the preparation of RBC or platelets, leuko-depleted by at least one log. Transfusion of LPBC must be done in a logical fashion that meets the needs of the patient. Currently, LPBC is indicated for patients with a history of nonhemolytic febrile transfusion reactions to delay alloimmunization to HLA antigens and avoidance of cytomegalovirus (CMV) infection.


Asunto(s)
Eliminación de Componentes Sanguíneos/métodos , Leucocitos , Transfusión de Componentes Sanguíneos , Humanos , Plaquetoferesis/métodos
19.
Transfusion ; 29(4): 362-4, 1989 May.
Artículo en Inglés | MEDLINE | ID: mdl-2718236

RESUMEN

Concern about the ineffectiveness of indirect questioning of donors about participation in activities with a high-risk of exposure to human immunodeficiency virus (HIV) led our two community blood centers independently to begin direct and explicit questioning of donors about such activities. The impact of direct questioning was assessed via a donor attitude survey and by comparing the number of donors deferred for a positive response to a direct verbal question with the number previously deferred for a positive response to indirect questions. Our donor attitude survey indicated 90% donor approval of direct questioning, and analysis of donor deferral patterns indicated almost a five-fold increase in the number of donors deferred for participation in high-risk activities. Our experience documents the acceptability of direct questioning of donors and indicates that such questioning may well have a positive impact on blood safety.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/transmisión , Donantes de Sangre/psicología , Transfusión Sanguínea/psicología , Participación de la Comunidad , Encuestas Epidemiológicas , Síndrome de Inmunodeficiencia Adquirida/psicología , California , Centros Comunitarios de Salud , Participación de la Comunidad/métodos , Participación de la Comunidad/tendencias , Confidencialidad , Femenino , Humanos , Entrevistas como Asunto , Masculino , Factores de Riesgo , Reacción a la Transfusión , Volición
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...